GHRS
Price
$13.65
Change
+$0.12 (+0.89%)
Updated
Sep 23 closing price
Capitalization
846.7M
43 days until earnings call
IVVD
Price
$1.16
Change
-$0.06 (-4.92%)
Updated
Sep 23 closing price
Capitalization
242.88M
49 days until earnings call
Interact to see
Advertisement

GHRS vs IVVD

Header iconGHRS vs IVVD Comparison
Open Charts GHRS vs IVVDBanner chart's image
GH Research
Price$13.65
Change+$0.12 (+0.89%)
Volume$225.62K
Capitalization846.7M
Invivyd
Price$1.16
Change-$0.06 (-4.92%)
Volume$1.59M
Capitalization242.88M
GHRS vs IVVD Comparison Chart in %
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. IVVD commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Buy and IVVD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (GHRS: $13.65 vs. IVVD: $1.16)
Brand notoriety: GHRS and IVVD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 78% vs. IVVD: 22%
Market capitalization -- GHRS: $846.7M vs. IVVD: $242.88M
GHRS [@Biotechnology] is valued at $846.7M. IVVD’s [@Biotechnology] market capitalization is $242.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 1 FA rating(s) are green whileIVVD’s FA Score has 0 green FA rating(s).

  • GHRS’s FA Score: 1 green, 4 red.
  • IVVD’s FA Score: 0 green, 5 red.
According to our system of comparison, both GHRS and IVVD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 6 TA indicator(s) are bullish while IVVD’s TA Score has 5 bullish TA indicator(s).

  • GHRS’s TA Score: 6 bullish, 2 bearish.
  • IVVD’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, GHRS is a better buy in the short-term than IVVD.

Price Growth

GHRS (@Biotechnology) experienced а +8.08% price change this week, while IVVD (@Biotechnology) price change was -7.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.75%. For the same industry, the average monthly price growth was +7.78%, and the average quarterly price growth was +47.65%.

Reported Earning Dates

GHRS is expected to report earnings on Nov 06, 2025.

IVVD is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($847M) has a higher market cap than IVVD($243M). IVVD YTD gains are higher at: 161.792 vs. GHRS (95.000). GHRS has higher annual earnings (EBITDA): -40.66M vs. IVVD (-110.21M). GHRS has more cash in the bank: 292M vs. IVVD (34.9M). GHRS has less debt than IVVD: GHRS (647K) vs IVVD (2.97M). IVVD has higher revenues than GHRS: IVVD (46.2M) vs GHRS (0).
GHRSIVVDGHRS / IVVD
Capitalization847M243M349%
EBITDA-40.66M-110.21M37%
Gain YTD95.000161.79259%
P/E RatioN/AN/A-
Revenue046.2M-
Total Cash292M34.9M837%
Total Debt647K2.97M22%
TECHNICAL ANALYSIS
Technical Analysis
GHRSIVVD
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 15 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IVVD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GBCS2.250.15
+7.14%
Selectis Health,Inc.
CUKPF28.80N/A
N/A
Carnival Plc
MLLUY5.31N/A
N/A
Metallurgical Corp China Ltd
TRZBF2.06N/A
N/A
Transat A.T. Inc.
SFRGY3.10-0.08
-2.64%
Salvatore Ferragamo S.P.A.

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with IVVD. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
+0.89%
IVVD - GHRS
36%
Loosely correlated
-4.92%
ATAI - GHRS
35%
Loosely correlated
+14.96%
ATHE - GHRS
31%
Poorly correlated
+0.72%
MNMD - GHRS
29%
Poorly correlated
+4.30%
CLDI - GHRS
26%
Poorly correlated
-0.62%
More

IVVD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IVVD has been loosely correlated with ENTO. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if IVVD jumps, then ENTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVVD
1D Price
Change %
IVVD100%
-4.92%
ENTO - IVVD
66%
Loosely correlated
+2.00%
GHRS - IVVD
37%
Loosely correlated
+0.89%
AVIR - IVVD
32%
Poorly correlated
-1.02%
CELC - IVVD
32%
Poorly correlated
+0.02%
ATAI - IVVD
30%
Poorly correlated
+14.96%
More